Mostafa Faisal Mohammed Saleh/LinkedIn
Jul 29, 2026, 16:30
Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
Mostafa Faisal, Associate Professor of Clinical Hematology and HSCT at Assiut University, shared a post on X about a recent article by Arnon Haran et al. published in European Journal of Hematology, adding:
“DNMT3A and TET2 Mutations are Associated With Both Venous Thrombosis and Major Bleeding in Patients With Polycythemia Vera and Essential Thrombocythemia.”
Title: DNMT3A and TET2 Mutations are Associated With Both Venous Thrombosis and Major Bleeding in Patients With Polycythemia Vera and Essential Thrombocythemia
Authors: Arnon Haran, Avital Wasserstrom, Vladimir Vainstein, Romi Kazoom, Ela Shai, Ariela Arad, Batia Roth, Noa Buchman, Yosef Kalish, Eran Zimran
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 13:56Binay Shah: Building a Future of Accessible Cancer Care
-
Aug 9, 2026, 13:44Taking Charge of Your Bleeding Disorder – National Bleeding Disorders Foundation
-
Aug 9, 2026, 13:17Andrew Zapfel: Building a Stronger Future for Sickle Cell Care in Kenya
-
Aug 9, 2026, 13:07Angelica Varesi: New Insights into Hematopoietic Stem Cell Biology
-
Aug 9, 2026, 12:48Paul Watton։ New Clues to the Cause of ME/CFS
-
Aug 9, 2026, 12:26Mohamed Rawy: When Is a Reduced DOAC Dose Appropriate?
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation